| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |